Epidemiol Mikrobiol Imunol. 2021 Spring;70(1):42-51.
The aim of our work was to summarize the most important knowledge about listeriosis in humans and to analyse available epidemiological data on this disease in the Czech Republic in 2008-2018.
We conducted a literature search and descriptive epidemiological analysis of all human Listeria cases reported to the national surveillance system of infectious diseases (EpiDat until 2017, ISIN for 2018) in the Czech Republic in 2008-2018. For data management and analysis, MS Excel 2010 was used. The incidence maps were created using the ECDC Map Maker tool (EMMa).
In total, 380 cases of human listeriosis (mean annual incidence of 0.33/100 000 inhabitants) were reported in the Czech Republic in 2008-2018. The highest age specific incidence was detected in 0-year-olds (1.85/100 000) and then in persons over 60 years (mean incidence of 0.95/100 000). Altogether 222 cases were detected in men (mean incidence of 0.39/100 000) and 158 in women (mean incidence of 0.27/100 000). Geographically, the highest mean annual incidence was reported in the Moravian-Silesian Region (0.6/100 000) and Pilsen Region (0.57/100 000). As many as 96.3% of the reported cases required hospital admission. Of 81 deaths related to listeriosis, 50 were directly caused by listeriosis. The highest monthly incidence was observed in June through October and then in January. The incidence of listeriosis in the CZ shows an oscillating trend over the last 11 years. Neither epidemics nor imported cases were reported to the national surveillance system during the study period.
Listeriosis cases have been on the rise in the European Union (EU) over the last years, while in the CZ, an oscillating and slightly increasing trend has been observed. Generally, cases are reported mostly in the population aged over 64 years (and especially after the age of 84). As there is no vaccine available yet against this disease, the only option is the prevention, i.e., health education of consumers in general and of the risk groups in particular, and compliance with food safety and hygiene standards in food production and handling.
我们的工作旨在总结人类李斯特菌病的最重要知识,并分析 2008-2018 年捷克共和国该病的现有流行病学数据。
我们对 2008-2018 年国家传染病监测系统(EpiDat 直至 2017 年,ISIN 用于 2018 年)报告的所有人类李斯特菌病例进行了文献检索和描述性流行病学分析。为了数据管理和分析,我们使用了 MS Excel 2010。发病率地图使用 ECDC Map Maker 工具(EMMa)创建。
2008-2018 年,捷克共和国共报告 380 例人类李斯特菌病(年发病率为 0.33/100000 居民)。在 0 岁年龄组中发现的特定年龄发病率最高(1.85/100000),然后是 60 岁以上人群(平均发病率为 0.95/100000)。共有 222 例男性(发病率为 0.39/100000)和 158 例女性(发病率为 0.27/100000)被检出。在地理上,发病率最高的是摩拉维亚-西里西亚地区(0.6/100000)和比尔森地区(0.57/100000)。报告的病例中有 96.3%需要住院治疗。81 例与李斯特菌病相关的死亡中,有 50 例直接由李斯特菌病引起。发病率最高的月份是 6 月至 10 月和 1 月。过去 11 年来,捷克共和国李斯特菌病的发病率呈波动趋势。在研究期间,国家监测系统没有报告该病的流行或输入病例。
近年来,欧盟(EU)的李斯特菌病病例呈上升趋势,而在捷克共和国,观察到的趋势是波动且略有上升。一般来说,报告的病例主要发生在 64 岁以上人群(尤其是 84 岁以上人群)。由于目前尚无针对该疾病的疫苗,因此唯一的选择是预防,即对消费者(特别是对高危人群)进行健康教育,以及遵守食品生产和处理中的食品安全和卫生标准。